about
CXC chemokines and chemokine receptors in gastric cancer: from basic findings towards therapeutic targetingParticipation of microbiota in the development of gastric cancerYin Yang 1 is a target of microRNA-34 family and contributes to gastric carcinogenesisGastric Cancer Associated Genes Identified by an Integrative Analysis of Gene Expression Data.Decreased expression of histone deacetylase 10 predicts poor prognosis of gastric cancer patients.VEZT, a novel putative tumor suppressor, suppresses the growth and tumorigenicity of gastric cancer.13-acetoxysarcocrassolide induces apoptosis on human gastric carcinoma cells through mitochondria-related apoptotic pathways: p38/JNK activation and PI3K/AKT suppressionMicroRNA-410 suppresses migration and invasion by targeting MDM2 in gastric cancer.MicroRNA-29c mediates initiation of gastric carcinogenesis by directly targeting ITGB1.Circulating MiR-16-5p and MiR-19b-3p as Two Novel Potential Biomarkers to Indicate Progression of Gastric Cancer.The MicroRNA-217 Functions as a Potential Tumor Suppressor in Gastric Cancer by Targeting GPC5Novel long non-coding RNA RP11-119F7.4 as a potential biomarker for the development and progression of gastric cancer.The reciprocal regulation loop of Notch2 pathway and miR-23b in controlling gastric carcinogenesis.By downregulating TIAM1 expression, microRNA-329 suppresses gastric cancer invasion and growthTCEA3 Attenuates Gastric Cancer Growth by Apoptosis Induction.Gelsolin-mediated activation of PI3K/Akt pathway is crucial for hepatocyte growth factor-induced cell scattering in gastric carcinoma.Serum Helicobacter pylori NapA antibody as a potential biomarker for gastric cancer.DLL4 overexpression increases gastric cancer stem/progenitor cell self-renewal ability and correlates with poor clinical outcome via Notch-1 signaling pathway activationIntestinal microbiota, probiotics and human gastrointestinal cancers.Roles of competing endogenous RNAs in gastric cancer.MiR-203 inhibits tumor invasion and metastasis in gastric cancer by ATM.MicroRNA-103a inhibits gastric cancer cell proliferation, migration and invasion by targeting c-Myb.Y-box binding protein 1 is correlated with lymph node metastasis in intestinal-type gastric cancer.Downregulation of tumor suppressor MBP-1 by microRNA-363 in gastric carcinogenesis.MicroRNA-561 inhibits gastric cancercell proliferation and invasion by downregulating c-Myc expression.MIR-519d suppresses the gastric cancer epithelial-mesenchymal transition via Twist1 and inhibits Wnt/β-catenin signaling pathwaymicroRNA-449a functions as a tumor-suppressor in gastric adenocarcinoma by targeting Bcl-2.Identification of key miRNAs and genes associated with stomach adenocarcinoma from The Cancer Genome Atlas database.MiR-361-5p suppresses chemoresistance of gastric cancer cells by targeting FOXM1 via the PI3K/Akt/mTOR pathway.Concurrent Treatment with Anti-DLL4 Enhances Antitumor and Proapoptotic Efficacy of a γ-Secretase Inhibitor in Gastric Cancer.Upregulation of HOXB7 promotes the tumorigenesis and progression of gastric cancer and correlates with clinical characteristics.
P2860
Q26849606-3CF039F0-DAE5-4F12-811B-0B7D1839DA3EQ27004607-7FED7010-5A4C-471C-8C9A-79D6F76352B2Q28393225-7EDEB74E-BF32-4137-9E14-991AB418B9ADQ31165479-A5748829-F734-4FF2-99E4-CFBC8D7C23FFQ34371426-D087726D-77B0-4E85-8265-2D676DCF0C92Q34373527-88BF5472-1DAC-468F-A0A2-CDEB24B72EDFQ34411580-DAFC2B11-D63F-4759-95F8-56A8D8BB3731Q35227870-C0F11529-F532-41C5-9DED-C19854839E9EQ35258620-5417DA39-D1A8-47BE-B5D2-13912C369F3CQ35475974-809BBCC0-B1EA-4682-ACD0-BD2B70D2F053Q35670548-FD4193DB-6632-48D7-AA25-AB4B99C0A280Q35803099-007B4FC6-E94F-48D5-AE10-D6BCC9BA0F78Q36228497-7C639DD6-19F2-4DFA-82A6-7427B018B276Q36232099-66F7A7B3-A000-4EC8-9D59-C883A28385DCQ36232247-7E65C597-D46C-4621-90B1-BEAE9931EE0BQ37295357-F9513F3C-84E0-4146-8262-A3BDB04A2A3CQ37594458-289BF5C8-AF55-4F44-9967-4310AC97E7D1Q37609471-A8B46BB3-AA64-4969-A3C6-1F7FD9EA1D92Q38062446-7C5DFE65-4AB1-4B3F-939F-D1FA737501CCQ38592603-1B05CF54-61AE-4C09-9C14-E8F39267903CQ38751011-B99273FD-6509-47CE-B958-366E96E17488Q38926425-6DA54B1A-90D0-413A-ADA1-D8F2F07D6D8CQ38951772-AD749AA6-B983-4ACB-890C-1705C3D1A925Q39105165-BAD4E7DF-6598-4BA3-A0C5-29A92D2B79F4Q41210209-474ACA70-54E2-4428-8105-D40C0B892D09Q41549301-A0871808-064A-4710-A5A0-8DD6D7976972Q42877563-6E53CC04-BB05-41D1-915C-C7B70395385FQ49438443-B9855601-3527-48F1-BFC5-9E73D0BC6EF4Q49740746-1C8B0C5B-E8A8-4983-BBA6-390B12A85302Q51735938-195B755F-5AF9-4D77-B20B-8479DD68680DQ52921944-A378DE07-6942-43B6-8228-934010B03C21
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Gastric cancer: basic aspects.
@en
type
label
Gastric cancer: basic aspects.
@en
prefLabel
Gastric cancer: basic aspects.
@en
P2860
P1433
P1476
Gastric cancer: basic aspects.
@en
P2093
Alexandra Thiel
Ari Ristimäki
P2860
P356
10.1111/J.1523-5378.2012.00979.X
P478
17 Suppl 1
P577
2012-09-01T00:00:00Z